AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19150417 — intervention group
Group type: EXPERIMENTAL
Intervention: Plethysmographic lung volume (TLCpleth)
Number of subjects: 55
Study 19150417 — intervention group
Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 55
Study 17477082 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-month ambulatory cardiac rehabilitation program (45-minute training with cycle ergometer, three times a week, and generally improving gym exercises, two times a week)
Number of subjects: 103
Study 17477082 — intervention group
Group type: COMPARATOR
Intervention: Control group (39 normotensive patients with coronary artery disease, mean age: 59.4 ± 1.3 years)
Number of subjects: 103
Study 15362143 — intervention group
Group type: EXPERIMENTAL
Intervention: In-home nursing intervention
Number of subjects: 240
Study 15362143 — intervention group
Group type: COMPARATOR
Intervention: Agency nursing care or no nursing care (Control)
Number of subjects: 240
Study 10803866 — intervention group
Group type: EXPERIMENTAL
Intervention: MICA allele A9
Number of subjects: 162
Study 9297379 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium (3 x ED95)
Number of subjects: 62
Study 9297379 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium (5 x ED95)
Number of subjects: 62
Study 9297379 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium (3 x ED90)
Number of subjects: 62
Study 9297379 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 62
Study 8153718 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous adrenaline
Number of subjects: 71
Study 8153718 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised salbutamol
Number of subjects: 71
Study 8153718 — intervention group
Group type: COMPARATOR
Intervention: Intravenous aminophylline
Number of subjects: 71
Study 3763651 — intervention group
Group type: EXPERIMENTAL
Intervention: Flupenthixol (0.5 mg for the first week, then doubled for 3 weeks)
Number of subjects: 192
Study 3763651 — intervention group
Group type: COMPARATOR
Intervention: Diazepam (2.5 mg for the first week, then doubled for 3 weeks)
Number of subjects: 192
Study 28918543 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-supplemented diet
Number of subjects: 2
Study 28918543 — intervention group
Group type: COMPARATOR
Intervention: DHA-free diet (control)
Number of subjects: 2
Study 28464804 — intervention group
Group type: EXPERIMENTAL
Intervention: LEACH program (LP)
Number of subjects: 248
Study 28464804 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 248
Study 26244932 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass
Number of subjects: 0
Study 26244932 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertical banded gastroplasty
Number of subjects: 0
Study 26244932 — intervention group
Group type: COMPARATOR
Intervention: Obese controls
Number of subjects: 0
Study 26244932 — intervention group
Group type: EXPERIMENTAL
Intervention: Germ-free mice colonized with stools from patients
Number of subjects: 0
Study 24565296 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol via patient‐controlled analgesia device (400 μg.kg(‐1), 5‐minute lockout interval, no basal infusion)
Number of subjects: 60
Study 24565296 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion using the same settings as Group P
Number of subjects: 60
Study 20857188 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping improvement group intervention (n = 104)
Number of subjects: 295
Study 20857188 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal support group intervention (n = 105)
Number of subjects: 295
Study 20857188 — intervention group
Group type: COMPARATOR
Intervention: ITUR control condition (n = 86)
Number of subjects: 295
Study 19004308 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Intensity Laser Therapy (LILT) - Infrared laser (780 nm, 70 mw, 60s, 105J/cm2), applied twice per week for a total of eight sessions
Number of subjects: 14
Study 19004308 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser treatment
Number of subjects: 14
Study 16800167 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention (normal foods)
Number of subjects: 75
Study 16800167 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dietary intervention)
Number of subjects: 75
Study 12699951 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic adhesiolysis
Number of subjects: 100
Study 12699951 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 100
Study 10723834 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment self-efficacy
Number of subjects: 60
Study 10723834 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive functioning
Number of subjects: 60
Study 10723834 — intervention group
Group type: EXPERIMENTAL
Intervention: Level of alcohol dependence
Number of subjects: 60
Study 9371207 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled frusemide (40 mg)
Number of subjects: 11
Study 9371207 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 11
Study 1532198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cl2MDP (300 mg IV for 7 days, then 200 mg IM for 14 days)
Number of subjects: 76
Study 1532198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cl2MDP (1,200 mg/d orally) plus chemotherapy (group B)
Number of subjects: 76
Study 1532198 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (group A)
Number of subjects: 76
Study 1532198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cl2MDP treatment in osteoblastic metastases
Number of subjects: 76
Study 1532198 — intervention group
Group type: EXPERIMENTAL
Intervention: Cl2MDP overall effectiveness
Number of subjects: 76
Study 31961975 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 0
Study 31961975 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 30656453 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D laparoscopic TME
Number of subjects: 88
Study 30656453 — intervention group
Group type: COMPARATOR
Intervention: 2D laparoscopic TME
Number of subjects: 88
Study 28503761 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with self-reported past gestational diabetes mellitus (pGDM)
Number of subjects: 2786
Study 28503761 — intervention group
Group type: COMPARATOR
Intervention: Women without self-reported past gestational diabetes mellitus (pGDM)
Number of subjects: 2786
Study 28503761 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with pGDM aged <40 years
Number of subjects: 2786
Study 28503761 — intervention group
Group type: COMPARATOR
Intervention: Women without pGDM aged <40 years
Number of subjects: 2786
Study 27412548 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed cord clamping (DCC)
Number of subjects: 90
Study 27412548 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC)
Number of subjects: 90
Study 24657491 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 45
Study 24657491 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 45
Study 22926182 — intervention group
Group type: EXPERIMENTAL
Intervention: Cobedding
Number of subjects: 67
Study 22926182 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 67
Study 19329235 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile bearing total knee prosthesis at 8 months postoperatively
Number of subjects: 0
Study 19329235 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile bearing total knee prosthesis at 3 years postoperatively
Number of subjects: 0
Study 18617099 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-implants as anchor units (G1)
Number of subjects: 40
Study 18617099 — intervention group
Group type: COMPARATOR
Intervention: Conventional methods of anchorage (G2)
Number of subjects: 40
Study 16021535 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram predictions
Number of subjects: 33
Study 16021535 — intervention group
Group type: COMPARATOR
Intervention: Clinical expert predictions
Number of subjects: 33
Study 16021535 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram results impact on surgical planning
Number of subjects: 33
Study 11876261 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterol esters (PSE) at a dosage of 3.6 g/d in salad dressings (ranch or Italian) for 3 weeks
Number of subjects: 53
Study 11876261 — intervention group
Group type: COMPARATOR
Intervention: Control diet (salad dressings without PSE)
Number of subjects: 53
Study 11876261 — intervention group
Group type: EXPERIMENTAL
Intervention: Plant sterol esters (PSE)
Number of subjects: 53
Study 9918342 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolcapone (200 mg three times daily)
Number of subjects: 146
Study 9918342 — intervention group
Group type: COMPARATOR
Intervention: Bromocriptine (titrated from 1.25 mg once daily to a mean final dose of 22.4 mg/day)
Number of subjects: 146
Study 9918342 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolcapone
Number of subjects: 146
Study 7554756 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine infusion (15 micrograms min‐1 kg‐1)
Number of subjects: 10
Study 7554756 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (50 W)
Number of subjects: 10
Study 1971503 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha), 35 x 10(6) units per day subcutaneously for at least 12 weeks
Number of subjects: 34
Study 1971503 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 35 x 10(6) units per day subcutaneously for at least 12 weeks
Number of subjects: 34
Study 6101676 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg of intravaginal purified porcine relaxin
Number of subjects: 30
Study 6101676 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 30
Study 31200830 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin added to single-agent chemotherapy
Number of subjects: 531
Study 31200830 — intervention group
Group type: COMPARATOR
Intervention: Single-agent chemotherapy without cisplatin
Number of subjects: 531
Study 27743290 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium ionophore A23187 alone (group A)
Number of subjects: 0
Study 27743290 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium ionophore A23187 + recombinant human GM‐CSF (group B)
Number of subjects: 0
Study 25802471 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin + GIMM (GI microbiome modulator)
Number of subjects: 10
Study 25802471 — intervention group
Group type: COMPARATOR
Intervention: Metformin + Placebo
Number of subjects: 10
Study 23981773 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D 5,000 IU daily
Number of subjects: 84
Study 23981773 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D 10,000 IU daily
Number of subjects: 84
Study 23981773 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 21356647 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous stage‐matched exercise and diet (SSED) intervention
Number of subjects: 45
Study 21356647 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study 19841999 — intervention group
Group type: EXPERIMENTAL
Intervention: Undocumented Latinos
Number of subjects: 4013
Study 19841999 — intervention group
Group type: EXPERIMENTAL
Intervention: Undocumented status
Number of subjects: 4013
Study 17693219 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 15153841 — intervention group
Group type: EXPERIMENTAL
Intervention: VEGF measured in cerebrospinal fluid (CSF) using solid-phase ELISA
Number of subjects: 0
Study 15153841 — intervention group
Group type: EXPERIMENTAL
Intervention: Recoverin measured in serum using immunoenzymetric assay
Number of subjects: 0
Study 11310932 — intervention group
Group type: EXPERIMENTAL
Intervention: Red Bull drink
Number of subjects: 13
Study 11310932 — intervention group
Group type: COMPARATOR
Intervention: Caffeine drink
Number of subjects: 13
Study 11310932 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink
Number of subjects: 13
Study 9385748 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser photocoagulation
Number of subjects: 0
Study 9385748 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitreoretinal surgical techniques
Number of subjects: 0
Study 7961322 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal-contact intervention with counseling and mailed urine cotinine test results and self-help manual
Number of subjects: 0
Study 7961322 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving counseling on health effects of passive smoking
Number of subjects: 0
Study 7961322 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 0
Study 3322569 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg once daily
Number of subjects: 77
Study 3322569 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 29980545 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic play intervention
Number of subjects: 208
Study 29980545 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 208
Study 26787791 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile flow CPB
Number of subjects: 40
Study 26787791 — intervention group
Group type: COMPARATOR
Intervention: Non-pulsatile flow CPB
Number of subjects: 40
Study 25680096 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental support programme (6 months duration) including health information for parents, motivational interviewing, and teacher-led classroom activities.
Number of subjects: 243
Study 23348870 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy (RT, n = 21)
Number of subjects: 52
Study 23348870 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiation (CRT, n = 21)
Number of subjects: 52
Study 23348870 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery + radiotherapy (SRT, n = 10)
Number of subjects: 52
Study 20539299 — intervention group
Group type: COMPARATOR
Intervention: Self-help group (SELF)
Number of subjects: 278
Study 20539299 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate physical activity (MOD-PA) 150 min/week
Number of subjects: 278
Study 20539299 — intervention group
Group type: EXPERIMENTAL
Intervention: High physical activity (HIGH-PA) 300 min/week
Number of subjects: 278
Study 20539299 — intervention group
Group type: COMPARATOR
Intervention: Weight-stable (WT-STABLE)
Number of subjects: 278
Study 20539299 — intervention group
Group type: COMPARATOR
Intervention: Weight-gain (WT-GAIN)
Number of subjects: 278
Study 20539299 — intervention group
Group type: COMPARATOR
Intervention: Weight-loss (WT-LOSS)
Number of subjects: 278
Study 18387397 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil (100 mg)
Number of subjects: 351
Study 18387397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study 17157654 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetone‐precipitated extract containing 0.6 mug Can f 1 per 0.5 mL maintenance dose
Number of subjects: 28
Study 17157654 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetone‐precipitated extract containing 3.0 mug Can f 1 per 0.5 mL maintenance dose
Number of subjects: 28
Study 17157654 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetone‐precipitated extract containing 15.0 mug Can f 1 per 0.5 mL maintenance dose
Number of subjects: 28
Study 17157654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 14511168 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (n=10)
Number of subjects: 22
Study 14511168 — intervention group
Group type: COMPARATOR
Intervention: Control (n=12)
Number of subjects: 22
Study 10575661 — intervention group
Group type: EXPERIMENTAL
Intervention: GLN-antioxidants (40 g/d)
Number of subjects: 26
Study 10575661 — intervention group
Group type: COMPARATOR
Intervention: Control (glycine 40 g/d)
Number of subjects: 26
Study 8701786 — intervention group
Group type: EXPERIMENTAL
Intervention: Mestranol (80 micrograms/day for 10 days)
Number of subjects: 13
Study 8701786 — intervention group
Group type: EXPERIMENTAL
Intervention: Mestranol plus paramethasone (80 micrograms + 6 mg/day for 10 days)
Number of subjects: 13
Study 1832761 — intervention group
Group type: EXPERIMENTAL
Intervention: rilmenidine 1 mg/day
Number of subjects: 90
Study 1832761 — intervention group
Group type: COMPARATOR
Intervention: atenolol 50 mg/day
Number of subjects: 90
Study 6224685 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg norfloxacin twice daily for ten days
Number of subjects: 61
Study 6224685 — intervention group
Group type: COMPARATOR
Intervention: 480 mg cotrimoxazole twice daily for ten days
Number of subjects: 61
Study 31728631 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/day)
Number of subjects: 78
Study 31728631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 30417614 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g TXA IV + 1 g TXA IA
Number of subjects: 90
Study 30417614 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g TXA IV + 2 g TXA IA
Number of subjects: 90
Study 30417614 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g TXA IV + 3 g TXA IA
Number of subjects: 90
Study 27797693 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week short message service intervention
Number of subjects: 384
Study 25026884 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone call intervention
Number of subjects: 1000
Study 25026884 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-monetary incentive (scientific book)
Number of subjects: 1000
Study 25026884 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 1000
Study 22142517 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI in women
Number of subjects: 747
Study 22142517 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI in men
Number of subjects: 747
Study 22142517 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating while doing another activity in men
Number of subjects: 747
Study 22142517 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating while doing another activity in women
Number of subjects: 747
Study 22142517 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-food meals in men
Number of subjects: 747
Study 20357033 — intervention group
Group type: EXPERIMENTAL
Intervention: High physical activity level maintained from T0 to T1
Number of subjects: 435
Study 20357033 — intervention group
Group type: COMPARATOR
Intervention: Low physical activity level
Number of subjects: 435
Study 20357033 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable body weight after diagnosis
Number of subjects: 435
Study 20357033 — intervention group
Group type: COMPARATOR
Intervention: Weight gain after diagnosis
Number of subjects: 435
Study 18789826 — intervention group
Group type: EXPERIMENTAL
Intervention: Late wake therapy (LWT) (sleep 21:00-01:00 h)
Number of subjects: 19
Study 18789826 — intervention group
Group type: COMPARATOR
Intervention: Early wake therapy (EWT) (sleep 03:00-07:00 h)
Number of subjects: 19
Study 15655136 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (50 mg OD)
Number of subjects: 0
Study 15655136 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan (600 mg OD)
Number of subjects: 0
Study 15655136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12847817 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor-based triple therapies
Number of subjects: 0
Study 12847817 — intervention group
Group type: EXPERIMENTAL
Intervention: H2-blockers based triple combinations lasting 10-14 days
Number of subjects: 0
Study 12847817 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical triple therapy (bismuth + 2 antimicrobials)
Number of subjects: 0
Study 12847817 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin-based therapies
Number of subjects: 0
Study 12847817 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroimidazoles-based therapies
Number of subjects: 0
Study 12847817 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin-based therapies
Number of subjects: 0
Study 12847817 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycyclin-based therapies
Number of subjects: 0
Study 10758085 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 10758085 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment for clustering
Number of subjects: 0
Study 8637342 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (500 mg orally)
Number of subjects: 20
Study 8637342 — intervention group
Group type: COMPARATOR
Intervention: Control (nothing)
Number of subjects: 20
Study 1593432 — intervention group
Group type: EXPERIMENTAL
Intervention: IOGEL 1103 capsular bag intraocular lenses
Number of subjects: 200
Study 2578365 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger movement (unilateral flexion of the index finger)
Number of subjects: 20
Study 2578365 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot movement (plantar flexion of the foot)
Number of subjects: 20
Study 2578365 — intervention group
Group type: COMPARATOR
Intervention: Comparison of finger and foot movements
Number of subjects: 20
Study 31034254 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose KS drinks
Number of subjects: 134
Study 31034254 — intervention group
Group type: COMPARATOR
Intervention: KME drinks
Number of subjects: 134
Study 31034254 — intervention group
Group type: EXPERIMENTAL
Intervention: KME+CHO drinks
Number of subjects: 134
Study 28742732 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy video
Number of subjects: 104
Study 28742732 — intervention group
Group type: COMPARATOR
Intervention: GERD video
Number of subjects: 104
Study 28742732 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall correlation
Number of subjects: 104
Study 26555862 — intervention group
Group type: EXPERIMENTAL
Intervention: Adant® (sodium hyaluronate injection)
Number of subjects: 229
Study 26555862 — intervention group
Group type: COMPARATOR
Intervention: Artz® (sodium hyaluronate injection)
Number of subjects: 229
Study 24760611 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity resistance training (HighR, 80% 1RM)
Number of subjects: 17
Study 24760611 — intervention group
Group type: COMPARATOR
Intervention: Low intensity resistance training (LowR, 40% 1RM)
Number of subjects: 17
Study 22446996 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 3761